Wound Care

Single Layered Skin Substitutes

Single Layered grafts are dehydrated amniotic membranes. The grafts are thin, fast acting, versatile. These membranes can be stored at room temperature. Membranes come in various sizes and are stored at ambient temperature with a 5 year shelf life.

Dual Layered Skin Substitutes

Dual Layered grafts are minimally manipulated preserving the properties exhibited in its natural state. These grafts are full of growth factors, cytokines, and have anti-inflammatory properties known to be critical in wound healing. Our grafts come in various sizes and are stored at ambient temperature with a 5 year shelf life.

Synthetic Skin Substitutes

We offer Innovative synthetic solutions that are great for HOPD Wound Clinics, ASC's and Hospital Operating Rooms. These solutions are fully synthetic and pose no risk of transmitting diseases or causing immunological reactions.

Triple Layered Skin Substitutes

Our Tri- Layered grafts are all minimally manipulated preserving the properties exhibited in its natural state. These grafts are full of growth factors, cytokines, and have anti-inflammatory properties known to be critical in wound healing. Our grafts come in various sizes and are stored at ambient temperature with a 5 year shelf life.

Quad Layered Skin Substitutes

Our Quad- Layered grafts are all minimally manipulated preserving the properties exhibited in its natural state. These grafts are full of growth factors, cytokines, and have anti-inflammatory properties known to be critical in wound healing. Our grafts come in various sizes and are stored at ambient temperature with a 5 year shelf life.

Platelet-Rich Plasma

PRP consists of cytokines, growth factors, chemokines, and a fibrin scaffold. This treatment is considered to be an advanced wound therapy for diabetic ulcers, burns and other traumatic external wounds that are non-healing. PRP accelerates wound healing significantly when injected to wound. PRP treatment is reimbursable for diabetic wound patients.

MolecuLight

The MolecuLight Wound Imaging Devices allow clinicians to quickly, safely, and easily visualize bacteria and measure wounds at the point of care, so they have maximum insights for accurate treatment selection and accelerated healing. There is a reimbursement pathway for the procedure “fluorescence wound imaging for bacterial presence, location, and load”1,2. The MolecuLight i:X® and MolecuLightDX™ are the only fluorescence imaging devices that enables this procedure. In a Randomized Controlled Trial published in ADA Journal on the use of Point-of-Care bacterial autofluoresence imaging concluded that the addition of Moleculight to SOC doubled 12-week healing rates of DFUs and improved wound closure. In a MolecuLight study by wound care expert Martha Kelso RN, CHWS, DAPWCA, HBOT
Chief Regulatory Officer & Founder of Wound Care Plus MolecuLight has profound transformative power that especially benefits Long Term Care and Skilled Nursing facilities.

Natrox

NATROX® O₂ is topical Oxygen therapy (TOT) directly to the wound. Patients with a chronic wound have a 71% greater chance of healing using NATROX® O2 therapy than with standard of care (SOC) alone. JWC Consensus Document states "TOT is an appropriate adjunctive therapy after 4 weeks of optimal SOC without achieving at least 50% reduction in wound area." NATROX® O₂ is a medical device that uses the natural the properties of oxygen to stimulate healing in previously non-healing wounds. It is non-invasive, comfortable, portable, and highly effective. TOT received an "A grade" recommendation as an adjunctive treatment for chronic DFU's by the ADA. Natrox many be used together with Hyperbaric Oxygen Therapy or with Skin Graft Substitutes (CAMPs) for improved outcomes. See evidence for TOT in Near-Infrared Spectroscopy here. NATROX® Wound Care has been featured in Practical Patient Care. Wound care experts Dr. Thomas Serena, Dr. Windy Cole, and Dr. Gregory Schultz share their expertise on why topical oxygen therapy is a promising new intervention for chronic, non-healing wounds.

Acellular Human Dermis Graft

Our dermal matrix is an acellular human dermis graft that is sterilized. The dermal matrix provides a natural scaffold to support the body’s regenerative processes. The dermal matrix produces a biocompatible intact porous scaffold to support cellular proliferation and revascularization. The key components of the native matrix that support the body’s regenerative processes.

Amniotic Membranes for Surgery

Membranes that are minimally processed human allograft which retains the structural properties of the extracellular matrix with proprietary aseptic processing methods maintaining the inherent growth factors and matrix proteins native to the tissue; all of which are known in literature for their roles within the natural closure of wounds. Available in multiple sizes.

We also offer amnion allografts that are available in single-layer and dual-layer specifically designed for use in the da Vinci Robot, that can also be used in laparoscopic surgery and open procedures, as well as for wound covering. The grafts have excellent strength, handling.

Non-Adherent Wound Dressing

Coming Soon! SUPRA NET® is specifically designed as a simple, comfortable, atraumatic wound contact layer. This material provides an optimal environment to facilitate rapid wound healing with a non-adherent surface for maximum patient comfort over a wide range of wounds and skin types. This hypoallergenic silicone-based material will readily conform to the wound surface and will gently adhere to the surrounding intact skin surface. SUPRA NET® provides good exudate management and handling characteristics. The dressing does not stick to the wound bed thereby minimizing pain during dressing changes while supporting the overall wound healing process.

PelashieldAM Synthetic Antimicrobial Burn Solution

PelashieldAM is a synthetic antimicrobial and biocompatible matrix for the management of burns. PelashieldAMTM contains precise levels of ionic and metallic silver to prevent and minimize microbial growth within the matrix. It provides sustained antimicrobial activity for up to 3 days and is 99.99% effective against microbes most frequently isolated in wound infections, including antibiotic resistant VRE and MRSA. The ultrathin form factor of PelashieldAM allows the matrix to conform to the burn wound tissue and provide a moist healing environment conducive to tissue growth. PelashieldAM has received as seen in "Dermatology Times" and on BioSpace.

Kerecis

We offer Kerecis Wound solutions for use in HOPD Wound/Burn Clinics, Hospital, Surgical, Private Office and even for Veterinary procedures. Kerecis offers outstanding Xenograft solutions for wound management. The Kerecis fish-skin grafts contain fat, protein, elastin, glycans, and other natural skin elements and are supplied in multiple shapes, variants, and sizes. The products are processed using Kerecis’ proprietary EnviroIntact™ method.

Microlyte Matrix

Microlyte® Matrix is an antimicrobial synthetic polymeric matrix used in the management of wounds. The fully synthetic multi-layer biocompatible matrix absorbs moisture to maintain a moist healing environment, while the ultra-low amounts of metallic and ionic silver provide broad spectrum antimicrobial benefits and prevent microbial colonization. As Microlyte® Matrix is placed onto the wound it transforms and contours to the underlying wound bed releasing powerful and broad-spectrum antimicrobial benefit without cytotoxicity. Microlyte can be seen in WOUNDS, the official journal of SWAC.

MicroDoc

The MicroDoc is a single-use and disposable Negative Pressure Wound Therapy system that reduces infection risk. Infections are a major cost in healthcare, MicroDoc helps reduce that cost. MicroDoc is mobile and ensures that patients can maintain their active lifestyles. MicroDoc has a reimbursement pathway in several settings.

Microlyte Ag/Lidocaine

Microlyte® Ag/Lidocaine is designed to facilitate wound healing progression in deteriorating wounds by suppressing the growth of microbes in contact with the dressing, maintaining a moist matrix environment conducive to cellular growth, and releasing lidocaine to effect local anesthetic action. Microlyte Ag/Lidocaine was shown to provide sustained antimicrobial activity in simulated wound fluid for several days, killing 99.99% of the most commonly identified clinical isolates of gram-positive and gram-negative bacteria, along with prevalent fungal strains. FDA cleared.

Offloading Boot

Diabetic foot ulcers (DFU’s) require offloading to heal. Shoes are ineffective and can no longer be the standard of care. Foot Defender combines a clinically proven design that reduces force with game-changing aesthetics for greater compliance. Developed by a multidisciplinary team of doctors, designers, and engineers, every component of Defender’s products has been the focus of rigorous engineering and testing to create superior healing environments for the foot. Contact us to order Defender for your patients and practice. Foot Defender can also be seen on Wound Source and on Podiatry Today.

NEAR INFRARED SPECTROSCOPY

NIR Spectroscopy uses near-infrared light to accurately and non-invasively assess tissue health and oxygenation. The images produced will help inform the providers next steps within the wound care continuum. Technology such as this not only saves limbs, but lives. Mimosa does have reimbursement.

Surgaflex Synthetic Antimicrobial Surgical Wound Solution

Surgaflex™ is a fully synthetic, ultrathin film matrix composed of polyvinyl alcohol with a surface coating containing ionic and metallic silver designed for use in the acute and surgical setting. Surgaflex™ absorbs wound fluid and contours to underlying wound bed with a powerful and broad-spectrum antimicrobial benefit without cytotoxicity. The polymeric matrix provides a moist healing environment that is conducive to wound healing. Surgaflex™ contains antimicrobial silver. Ionic and metallic silver. This addition of ionic and metallic silver provides rapid, effective, and sustained antimicrobial activity. Surgaflex can be seen on WOUNDS the official journal of SWAC.

Omeza OCM

OCM™ wound matrix is a first of it’s kind, drug-device combination product that provides comprehensive therapy for all phases of wound healing; reduces biofilm formation, reduce inflammation, increase proliferation and support remodeling. OCM™ wound matrix provides pharmaceutical grade time-released elements that migrate into the tunnels and crevices of the wound bed to support each stage of wound healing. OCM™ is delivered in single use, disposable vials. OCM can be used on effectively on an infected wound while the infection is being treated. OCM may also be used after skin substitute insurance coverage has run out or even prior to skin substitute use. Here are some OCM clinical studies displaying versatility and multi-modal effects by reducing bacterial contamination. Omeza OCM is not only backed by science but also by the experience of Dr. Desmond Bell, the Founder and President of “The Save A Leg, Save A Life” Foundation, a former member of the Board of Directors of the American Board of Wound Management, a frequent lecturer and author on the subject of wound care, peripheral arterial disease and diabetes, an editorial Board Member of “Today’s Wound Clinic”, a regular contributor to “Podiatry Today”, Frist Humanitarian Award winner, a Fellow of the Royal College of Physicians and Surgeons of Glasgow, and now the Chief Medical Officer at Omeza.

Novel Wound Care Hybrid drug-medical device